Peli BioThermal Expands European Manufacturing Centre
News Oct 05, 2017
Peli BioThermal has announced the expansion of its European manufacturing capabilities in France.
This extension is in response to meet the rising requirements of the worldwide transportation of pharmaceuticals throughout Europe and globally.
David Williams, President of Peli BioThermal, said: “I’m pleased to announce the extension of our production capability in France, to manufacture our single use bulk thermal shipper CoolPall™ Vertos. It is an exciting development and customers will benefit from the consistent quality and processes implemented worldwide.
“These significant changes and investments represent the ongoing efforts that Peli BioThermal is making and are a clear indication of our commitment to our customers, the industry and our global expansion of manufacturing and services.”
This implementation of the additional European manufacturing capabilities complements the company’s expanding existing facilities, providing solutions for customers globally, which included the recent introduction of new service centres in Belgium and Puerto Rico.
The latest European expansion demonstrates the company’s commitment to significant investment to serve customers globally and follows the qualification of production of the company’s reusable Crēdo Cube™ line of thermal shippers at its facility in the United Kingdom and the expanded manufacturing capability for the single-use Chronos™ Advance, Chronos™ Express and CoolPall™ Vertos product lines to its facility in the United States.
Screening for Disease or Toxins in a Drop of BloodNews
Scientist have developed a multinozzle emitter array (MEA), a silicon chip that can dramatically shorten the time it takes to identify proteins, peptides, and other molecular components within small volumes of biological samples.READ MORE
Phenogenetic Map Created For Stem Cell Models Of Neurological DiseasesNews
Researchers at The Ohio State University Wexner Medical Center have performed the first meta-analysis of all induced pluripotent stem cell models for neurological and neurodegenerative diseases, and created an atlas of how cell characteristics are linked to their genotype.READ MORE
Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF DiagnosticsNews
EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body now available on Ortho’s VITROS® 4600 Chemistry System and VITROS® 5600 Integrated System.READ MORE